Company Goals for 2013 Include Introduction of Smaller 50cc Total Artificial Heart and FDA Approval of the Freedom® Portable Driver and HDE for Destination Therapy (Press Release)Continue reading
Category Archives: AZBio News
Biocentury This Week: Computing for Cures
From Cold War computing on the West Coast to genome sequencing in Manhattan and FDA data mining in Washington, how advances in computer hardware and software promise to transform how drugs are discovered and developed.
The newest edition of BioCentury This Week television is joined by:
• |
Dr. Fred Streitz, Director of the Institute for Scientific Computing Research at Lawrence Livermore National Laboratory, who explains how high-performance computing is being used to precisely simulate 370 million cells in the human heart. |
• |
Dr. Eric Perakslis, Chief Information Officer at FDA, on the agency’s progress in harnessing mountains of clinical trial data. |
• |
Nancy Kelley, Executive Director and COO of the New York Genome Center, who describes the Big Apple’s ambitious efforts to merge medicine and information technology. |
NOTICE: BioCentury Publications, Inc., and WUSA-TV own the copyright to the program content on “BioCentury This Week,” and except for limited use of these links to the BioCenturytv.com website, BioCentury and WUSA prohibit hosting of BioCentury This Week program content by unauthorized third parties or posting of BioCentury This Week content to any unauthorized third party websites such as YouTube. Other BioCenturytv.com content and all trademarks are the property of BioCentury or WUSA-TV or other third parties.
Ruby red coupe raises funds for cancer investigations at non-profit TGen
40th anniversary Chevy Corvette raffled at 2013 Barrett-Jackson Collector Car AuctionContinue reading
Home for the Holidays: 1st SynCardia Total Artificial Heart Patient Discharged from UCLA
35-Year-Old Chad Washington Rejected His First Donor Heart, Waits for Second TransplantContinue reading
Apply to be a TGen Helios Scholar
The Translational Genomics Research Institute (TGen) is pleased to announce the 2013 application opening for the Helios Scholars paid summer internship program in biomedical research!Continue reading
Ernst and Young “Fire Power” Report Looks at Closing the Gap
Big pharma will increasingly tap M&A to close $100 billion growth gap, but path to deals grows more complex
Ernst & Young’s newly released “Firepower Index” finds big pharma’s capacity for M&A has decreased just when it needs transactions for growth and shareholder returnsContinue reading
Molecular Cancer Diagnostics on BioCentury This Week
The newest edition of BioCentury This Week television explores the molecular diagnostic conundrum — where tests are expected to show the kind of clinical evidence required for drugs, but without the reward system that exists for therapeutics.Continue reading
A bit of certainty for biotech investors and innovators added to “The Fiscal Cliff Bill” this week
This week’s “Fiscal Cliff Bill” included some key provisions that help support biotech innovations here in Arizona. Continue reading
The Tomorrow Project Comes to Biodesign
Intel’s Tomorrow Project asks… What kind of future are you imagining? What kind of future do you want to live in? What future do you want to avoid?
Through conversations about the future, can we make that future better? The Tomorrow Project sets forth that “if we want to imagine a better future and then build it then we need to change the story we are telling ourselves about the future we want to live in.”
In the videos below, Intel Futurist Brian David Johnson visits with thought leaders at The Biodesign Institute at Arizona State University to explore the possibilities for shaping health, science and a better tomorrow…
(To learn more about The Tomorrow Project, Click Here.)
Biodesign, Biosignatures and Sensorbots with Deirdre Meldrum
Brian David Johnson talks to Deirdre Meldrum — ASU Senior Scientist, Director of the Center for Biosignatures Discovery Automation in the Biodesign Institute at ASU, and Professor of Electrical Engineering – about transforming healthcare by detecting diseases before any symptoms appear. For instance, detecting lung cancer before a CT image would. Other topics include the development of Sensorbots monitoring biogeochemical processes in the ocean.
Biodesign, Science, and Stories of Possible Futures – a Conversation with Michael Birt
Intel futurist, Brian David Johnson talks with Michael Birt to contemplate a future in which people have a greater degree of personal control over predicting and preventing disease. Michael is the Director of the Center for Sustainable Health and Interim Co-director at Arizona State University’s Biodesign Institute – and author of a medical thriller set in Japan.